Browsing by Author Best, James

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2007Abstract 3691: Features Of Metabolic Syndrome Identify Individuals With Type 2 Diabetes Mellitus At High Risk For Cardiovascular Events And Greater Absolute Benefits Of FenofibrateBarter, Philip; Copt, Samuel; Keech, Anthony (Tony); Pardy, Christopher; Best, James; D'Emden, Michael C.; Drury, P; Ehnholm, Christian; FIELD study investigators, Fenofibrate Intervention and Event Lowering in Diabetes; Kesaniemi, Y. Antero; Scott, Russell; Taskinen, M.; Tse, Dana; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAbstract 3691: Features Of Metabolic Syndrome Identify Individuals With Type 2 Diabetes Mellitus At High Risk For Cardiovascular Events And Greater Absolute Benefits Of Fenofibrate, Circulation (Baltimore), vol.116, N/A,pp II_838-N/A
2012The Australian Primary Care Collaboratives Program: improving diabetes careColagiuri, Stephen; Audehm, Ralph; Best, James; Ford, Dale; Knight, Andrew; Central Clinical School: MedicineThe Australian Primary Care Collaboratives Program: improving diabetes care, Quality and Safety in Health Care, vol.21, 11, 2012,pp 956-963
2006Correction to the FIELD study reportBarter, Philip; Best, James; Keech, Anthony (Tony); Scott, R; Simes, Robert John; Taskinen, M; Central Clinical School: Medicine; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineCorrection to the FIELD study report, The Lancet, vol.368,(9545),2006,pp 1415-N/A
2009Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trialKeech, Anthony (Tony); Li, Li Ping; Rajamani, Kushwin; Voysey, Merryn; Baker, John R.; Best, James; Coleman, Peter G.; D'Emden, Michael C.; FIELD study investigators, Fenofibrate Intervention and Event Lowering in Diabetes; Laakso, Markku; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreEffect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial, The Lancet, vol.373, 9677, 2009,pp 1780-1788
2005Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.Barter, Philip; Best, James; Davis, Tracey; Forder, Peta; Glasziou, Paul; Keech, Anthony (Tony); Pillai, Avineshwaran; Scott, R; Simes, Robert John; Sullivan, David; Taskinen, M; Drury, P; et, al; Kesaniemi, Y. Antero; Central Clinical School: Medicine; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Molecular Bioscience; Central Clinical School: MedicineEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial., The Lancet, vol.366,(9500),2005,pp 1849-1861
2014Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyKeech, Anthony (Tony); Li, Li Ping; Mann, Kristy; Zannino, Diana; Best, James; dEmden, Michael; Jenkins, Alicia; Park, Kris; Saltevo, Juha; Stuckey, B G A; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreFavourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, Diabetologia, vol.57, 11, 2014,pp 2296-2303
2005Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]Barter, Philip; Best, James; Forder, Peta; Keech, Anthony (Tony); Scott, R; Simes, Robert John; Taskinen, M; Central Clinical School: Medicine; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineFenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481], Cardiovascular Diabetology 2005, vol.4,(13),2005,pp 1-9
2006The FIELD study - ReplyBarter, Philip; Best, James; Keech, Anthony (Tony); Scott, R; Simes, Robert John; Taskinen, M; Central Clinical School: Heart Research Institute; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineThe FIELD study - Reply, The Lancet, vol.367, 9517,pp 1142-1143
2010A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trialsByth Wilson, Karen; Keech, Anthony (Tony); O'Connell, Rachel; Pardy, Christopher; Simes, Robert John; Voysey, Merryn; Best, James; Ehnholm, Christian; Glasziou, Paul; Scott, Russell; Sullivan, David; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreA novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials, P L o S One, vol.5, 1,pp e8580-1-e8580-10
2004Significant lipid changes in a large-scale trial of fenofibrate to prevent cardiovascular disease in type 2 diabetesBarter, Philip; Forder, Peta; Keech, Anthony (Tony); Simes, Robert John; Best, James; FIELD study investigators, Fenofibrate Intervention and Event Lowering in Diabetes; Scott, Russell; Taskinen, M.; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSignificant lipid changes in a large-scale trial of fenofibrate to prevent cardiovascular disease in type 2 diabetes, Journal of the American College of Cardiology, vol.43, 5,pp A462-A462